A metal-polyphenol network-based iron supplement with improved stability and reduced gastrointestinal toxicity for iron deficiency anemia therapy
Source abstract
Abstract
Iron deficiency anemia (IDA) is a global health concern, particularly affecting women and children of reproductive age. Although oral iron supplements are the standard treatment for IDA, their bioavailability is often compromised by food interactions, and they are associated with significant gastrointestinal side effects. To overcome these limitations, we developed a novel iron nano-supplement, TA-Fe NPs, based on metal-polyphenol networks (MPNs) formed through the coordination of tannic acid (TA) and Fe 3+ . These uniform nanoparticles (∼190 nm) offer enhanced chemical stability and reduced food interference compared to traditional iron supplements. The polyphenolic TA component provides antioxidant properties, effectively mitigating oxidative stress and inflammation induced by free iron ions. To further improve stability and intestinal absorption, TA-Fe NPs were encapsulated in an enteric coating (TA-Fe@L100) to protect against acidic conditions in the stomach. In a mouse model of IDA, TA-Fe@L100 demonstrated superior therapeutic efficacy compared to FeSO 4 , including improvements in hematological parameters, organ iron storage, and gut microbiota balance. Importantly, TA-Fe@L100 alleviated common gastrointestinal side effects associated with iron supplementation, presenting a promising alternative for IDA treatment. Our findings suggest that TA-Fe@L100 is a cost-effective and biocompatible oral iron supplement with minimal side effects, offering significant potential for broader clinical application in the management of IDA. Iron deficiency anemia (IDA) is a global health issue, especially in women and children of reproductive age. Oral iron supplements are commonly used to treat IDA but have limited bioavailability and cause gastrointestinal side effects. To address these issues, we developed TA-Fe NPs, a novel iron nano-supplement based on metal-polyphenol networks (MPNs) of tannic acid (TA) and Fe 3+ . These nanoparticles (∼190 nm) offer enhanced stability and reduced food interference. The TA component also provides antioxidant benefits, reducing oxidative stress. Encapsulated in an enteric coating (TA-Fe@L100) for improved stability and absorption, TA-Fe@L100 showed superior therapeutic effects in a mouse IDA model compared to FeSO 4 , including better hematological outcomes, iron storage, and gut microbiota balance. Additionally, it reduced gastrointestinal side effects, making it a promising, cost-effective alternative for IDA treatment with minimal side effects.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Iron Metabolism and Disorders · Erythropoietin and Anemia Treatment · Folate and B Vitamins Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. The role of iron homeostasis in remodeling immune function and regulating inflammatory disease10.1016/j.scib.2021.02.010 ↗
2. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 202110.1016/S2352-3026(23)00160-6 ↗
3. Iron deficiency10.1016/S0140-6736(20)32594-0 ↗
4. Iron supplementation and iron-fortified foods: a review10.1080/10408398.2021.1876623 ↗
5. Ironing out mechanisms of iron homeostasis and disorders of iron deficiency10.1172/JCI148671 ↗
6. Iron metabolism: pathophysiology and pharmacology10.1016/j.tips.2021.05.001 ↗
7. Oral iron supplementation: new formulations, old questions
8. Mechanism and intervention measures of iron side effects on the intestine10.1080/10408398.2019.1630599 ↗
9. Fenton metal nanomedicines for imaging-guided combinatorial chemodynamic therapy against cancer
10. The impacts of iron overload and ferroptosis on intestinal mucosal homeostasis and inflammation10.3390/ijms232214195 ↗
11. Iron absorption: factors, limitations, and improvement methods10.1021/acsomega.2c01833 ↗
12. Oral ferric Maltol for the treatment of iron-deficiency anemia in patients with CKD: a randomized trial and open-label extension10.1053/j.ajkd.2021.03.020 ↗
13. Iron deficiency anemia: a comprehensive review on iron absorption, bioavailability and emerging food fortification approaches10.1016/j.tifs.2020.02.021 ↗
14. pH-triggered, synbiotic hydrogel beads for in vivo therapy of iron deficiency anemia and reduced inflammatory response10.1021/acsabm.1c00720 ↗
15. A safe and efficient method for encapsulation of ferrous sulfate in solid lipid nanoparticle for non-oxidation and sustained iron delivery10.1016/j.colcom.2019.100227 ↗
16. Influence of exopolysaccharide EPSKar1–iron complexation on iron bioavailability and alleviating iron deficiency anaemia in Wistar rats10.1039/D2FO03352F ↗
17. Metal–organic frameworks for biomedical applications10.1002/smll.201906846 ↗
18. Polyphenol-containing nanoparticles: synthesis, properties, and therapeutic delivery10.1002/adma.202007356 ↗
19. Metal-phenolic networks for cancer theranostics10.1039/D0BM02064H ↗
20. CaGA nanozymes with multienzyme activity realize multifunctional repair of acute wounds by alleviating oxidative stress and inhibiting cell apoptosis10.1039/D4BM01155D ↗
21. Ferrous ions doped calcium carbonate nanoparticles potentiate chemotherapy by inducing ferroptosis10.1016/j.jconrel.2022.06.002 ↗
22. Coating dormant collagenase‐producing bacteria with metal‐anesthetic networks for precision tumor therapy10.1002/advs.202407402 ↗
23. Cuproptotic nanoinducer-driven proteotoxic stress potentiates cancer immunotherapy by activating the mtDNA–cGAS–STING signaling10.1016/j.biomaterials.2024.122512 ↗
24. Natural product curcumin-based coordination nanoparticles for treating osteoarthritis via targeting Nrf2 and blocking NLRP3 inflammasome10.1007/s12274-021-3864-3 ↗
25. Metal‐phenolic nanomaterial with organelle‐level precision primes antitumor immunity via mtDNA‐dependent cGAS‐STING activation10.1002/anie.202411498 ↗
26. Mn-phenolic networks as synergistic carrier for STING agonists in tumor immunotherapy10.1016/j.mtbio.2024.101018 ↗
27. Anti‐PD‐L1 DNAzyme loaded photothermal Mn2+/Fe3+ hybrid metal‐phenolic networks for cyclically amplified tumor ferroptosis‐immunotherapy
28. Radicals scavenging MOFs enabling targeting delivery of siRNA for rheumatoid arthritis therapy10.1002/smll.202202604 ↗
29. Encoding bacterial colonization and therapeutic modality by wrapping with an adhesive drug-loadable nanocoating10.1016/j.mattod.2023.01.001 ↗
30. Tannic acid-based metal-phenolic networks as a versatile platform to mediate cell therapy10.1007/s40843-024-3139-3 ↗
31. Study of complexes of tannic acid with Fe(III) and Fe(II)
32. Fe(II) redox chemistry in the environment10.1021/acs.chemrev.0c01286 ↗
33. Tannic acid and zinc ion coordination of nanase for the treatment of inflammatory bowel disease by promoting mucosal repair and removing reactive oxygen and nitrogen species10.1016/j.actbio.2024.02.015 ↗
34. W-GA nanodots restore intestinal barrier functions by regulating flora disturbance and relieving excessive oxidative stress to alleviate colitis10.1016/j.actbio.2024.05.030 ↗
35. H2S‐Releasing versatile montmorillonite nanoformulation trilogically renovates the gut microenvironment for inflammatory bowel disease modulation10.1002/advs.202308092 ↗
36. Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy10.1016/j.jcis.2024.05.162 ↗
37. Antioxidant mechanism of tea polyphenols and its impact on health benefits10.1016/j.aninu.2020.01.001 ↗
38. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases10.1038/s41420-021-00579-w ↗
39. The stability of MOFs in aqueous solutions—research progress and prospects10.1016/j.gce.2023.07.004 ↗
40. Chemical, thermal and mechanical stabilities of metal–organic frameworks10.1038/natrevmats.2015.18 ↗
41. Sucrosomial® iron supplementation in mice: effects on blood parameters, hepcidin, and inflammation10.3390/nu10101349 ↗
42. Iron metabolism and iron deficiency anemia in women10.1016/j.fertnstert.2022.08.014 ↗
43. Iron deficiency anemia: a critical review on iron absorption, supplementation and its influence on gut microbiota10.1039/D3FO04644C ↗
44. Gut microbiome–short-chain fatty acids interplay in the context of iron deficiency anaemia10.1007/s00394-021-02645-6 ↗
45. The role of the gut microbiota in depressive-like behavior induced by chlorpyrifos in mice10.1016/j.ecoenv.2022.114470 ↗
46. Alterations in gut microbiota are related to metabolite profiles in spinal cord injury10.4103/1673-5374.355769 ↗
47. Polyphenol-rich vinegar extract regulates intestinal microbiota and immunity and prevents alcohol-induced inflammation in mice10.1016/j.foodres.2020.110064 ↗
48. Gut microbial dysbiosis correlates with stroke severity markers in aged rats10.3389/fstro.2022.1026066 ↗
49. Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium
50. The gut bacteria dysbiosis contributes to chronic graft-versus-host disease associated with a treg/Th1 ratio imbalance
51. A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes10.1158/2159-8290.CD-20-0537 ↗
52. Nontoxigenic Bacteroides fragilis: a double-edged sword10.1016/j.micres.2024.127796 ↗
53. Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p10.1053/j.gastro.2021.08.003 ↗
54. Transkingdom interactions between Lactobacilli and hepatic mitochondria attenuate western diet-induced diabetes10.1038/s41467-020-20313-x ↗
55. Alterations of bile acids and gut microbiota in obesity induced by high fat diet in rat model10.1021/acs.jafc.9b00249 ↗